2022
Development of a Parent-Reported Outcome Measure for Febrile Infants ≤60 Days Old
Aronson PL, Fleischer E, Schaeffer P, Fraenkel L, Politi MC, White MA. Development of a Parent-Reported Outcome Measure for Febrile Infants ≤60 Days Old. Pediatric Emergency Care 2022, 38: e821-e827. PMID: 35100782, PMCID: PMC8807943, DOI: 10.1097/pec.0000000000002378.Peer-Reviewed Original ResearchConceptsParent-reported outcome measureParents' emotionsPsychometric propertiesFebrile infants 60 daysMeasure's psychometric propertiesPotential itemsCognitive interviewsEmotionsItem clarityParents' experiencesInfants 60 daysParentsOutcome measuresDecision makingFinal measureItemsMeasuresInfant outcomesInterviewsExperienceNew samplesClarityFearExpert reviewEase of use
2013
Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.
White MA, Grilo CM. Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial. The Journal Of Clinical Psychiatry 2013, 74: 400-6. PMID: 23656848, PMCID: PMC4021866, DOI: 10.4088/jcp.12m08071.Peer-Reviewed Original ResearchConceptsBinge-eating disorderPlacebo-controlled trialObese womenOutcome measuresWeight lossDSM-IV-TR research criteriaTreatment of BEDInappropriate weight compensatory behaviorsRandomized placebo-controlled trialShort-term weight lossFood cravingsPercent BMI lossSecondary outcome measuresPrimary outcome measureShort-term efficacyTerm weight lossBinge-eating frequencySignificant time effectStand-alone treatmentLong-term trialsBMI lossPlacebo groupLifestyle interventionOverweight womenRandomized participants